24 Results for: created: (01/2018 to 01/2018)

People

  1. Zelefsky
    Zelefsky
  2. Kollmeier
    Kollmeier
  3. Cohen
    Cohen
  4. Pei
    Pei
  5. Cox
    Cox
  6. McBride
    McBride
  7. Taggar
    Taggar
  8. Yamada
    Yamada
  9. Charas
    Charas
  10. Damato
    Damato

Groups

  1. Survivorship Research (24)
  2. GDMT, Radiation Oncology (11)
  3. Gynecology Disease Management Team (11)
  4. Radiation Oncology, Department of (11)
  5. Medical Physics (9)
  6. Sloan Kettering Institute Postdocs (5)
  7. Radiotherapy Physics Service (4)
  8. Surgery (3)
  9. Biostatistics Service (2)
  10. Epidemiology and Biostatistics (2)
  1. "Michael Zelefsky"
Formats
  1. Book Section (11)
  2. Meeting Abstract (7)
  3. Journal Article (6)
Groups
  1. Survivorship Research (24)
  2. GDMT, Radiation Oncology (11)
  3. Gynecology Disease Management Team (11)
  4. Radiation Oncology, Department of (11)
  5. Medical Physics (9)
  6. Sloan Kettering Institute Postdocs (5)

More Groups

People
  1. Michael Zelefsky (24)
  2. Marisa Kollmeier (10)
  3. Gilad Cohen (6)
  4. Xin Pei (5)
  5. Brett Cox (4)
  6. Amandeep Taggar (3)

More People

Years
  1. 2018 (1)
  2. 2017 (6)
  3. 2013 (1)
  4. 2012 (3)
  5. 2011 (1)
  6. 2009 (2)

More Years

Publications
  1. Brachytherapy (4)
  2. Head and Neck Cancer: A Multidisciplinary Approach. 1st ed (3)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Radiotherapy and Oncology (3)
  5. Cancer: Principles and Practice of Oncology. 6th ed (2)
  6. American Journal of Hematology/Oncology (1)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. Elsevier Science, Inc. (5)
  3. Lippincott Williams & Wilkins (5)
  4. Lippincott-Raven (3)
  5. Demos Medical Publications (1)
  6. Haymarket Media Inc. (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate-specific antigen (PSA) bounce after dose-escalated external beam radiation therapy is an independent predictor of PSA recurrence, metastasis, and survival in prostate adenocarcinoma patients
    Journal Article

    Romesser, P. B.; Pei, X.; Shi, W.; Zhang, Z.; Kollmeier, M.; McBride, S. M.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with Pd-103 seeds
    Meeting Abstract

    Taggar, A. S.; Charas, T.; Weg, E.; Kollmeier, M.; Zelefsky, M. J.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Changes in seed configuration within prostate with implantation of a hydrogel rectal spacer and Its impact on urethral dose
    Meeting Abstract

    Taggar, A. S.; Mathur, N.; Charas, T.; Cohen, G. N.; Mangal, S.; Kollmeier, M.; Zelefsky, M. J.; Damato, A. L.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Day 0 dosimetric evaluation for LDR prostate brachytherapy may be superior to day 30 assessments by providing similar quality assurance information at earlier time points
    Meeting Abstract

    King, M. T.; Cohen, G. N.; Kollmeier, M. A.; Pei, X.; Damato, A. L.; Zelefsky, M. J.
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Multi-institutional phase 2 trial of high-dose stereotactic body radiation therapy with temporary hydrogel spacer for low- and intermediate-risk prostate cancer
    Meeting Abstract

    Folkert, M. R.; Zelefsky, M. J.; Hannan, R.; Desai, N. B.; Lotan, Y.; Laine, A. M.; Kim, D. W. N.; Hardee, S.; Hornberger, B.; Kollmeier, M. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2017)

    Fulltext@MSK | Save
  • Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: Lessons learned from prospective trials
    Journal Article

    Jones, R. T.; Hassan Rezaeian, N.; Desai, N. B.; Lotan, Y.; Jia, X.; Hannan, R.; Kim, D. W. N.; Hornberger, B.; Dubas, J.; Laine, A. M.; more...
    Medical Dosimetry (2017)

    Fulltext@MSK | Save
  • Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time
    Journal Article

    Kollmeier, M. A.; McBride, S.; Taggar, A.; Anderson, E.; Lin, M.; Pei, X.; Weiji, S.; Voros, L.; Cohen, G.; Yamada, Y.; more...
    Brachytherapy (2017)

    Fulltext@MSK | Save
  • Utilization of hormonal therapy with dose-escalated radiation therapy in the management of intermediate-risk prostate cancer
    Book Section

    Nguyen, P. L.; Zelefsky, M. J.; Monroe, A. T.; Liauw, S. L.
    In Small, W. Jr; Williams, T. R.; Donnelly, E. D. (Eds.) Radiation Oncology: Difficult Cases and Practical Management (2013)

    Fulltext@MSK | Save
  • A dosimetric analysis of prostate cancer treatment: Can SBRT really achieve what HDR can?
    Meeting Abstract

    Spratt, D. E.; Scala, M.; Cohen, G. N.; Happersett, L.; Zelefsky, M. J.; Kollmeier, M.; Cox, B.; Yamada, Y.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save
  • V150 predicts erectile outcome in patients undergoing low-dose-rate (LDR) brachytherapy alone for prostate cancer
    Meeting Abstract

    Kollmeier, M. A.; Scala, L. M.; Kunaprayoon, D.; Mathur, N.; Cohen, G.; Pei, X.; Zhang, Z.; Mulhall, J.; Cox, B.; Zelefsky, M. J.
    Radiotherapy and Oncology (2012)

    Fulltext@MSK | Save